Clinical Trials Browser

Phase 1/2 × Recurrence × Immunotherapy, Adoptive × Clear all

NCT03919240 2024-10-24

CAR-T Cell Therapy Targeting to CD19 for R/R ALL

Phase 1/2 Active not recruiting

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04790747 2021-03-10

Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions

Phase 1/2 Unknown

Other hematologic neoplasm

Recurrence, Hematologic Neoplasms